A structure-based approach was employed to design a new class of small-molecule inhibitors of Bcl-2. The most potent compound 5 (TW-37) binds to Bcl-2 with a K(i) value of 290 nM and also to Bcl-xL and Mcl-1 with high affinities. Compound 5 potently inhibits cell growth in PC-3 prostate cancer cells with an IC(50) value of 200 nM and effectively induces apoptosis in a dose-dependent manner.
Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins. Publishing Authors By Initials
Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins. Journal Published:
PUBLICATION TYPE: Research Support, U.S. Gov't,
Journal: Journal of medicinal chemistry
VOLUME: 49
Page Numbers: 6139-42
Journal Abbreviation: J. Med. Chem.
ISSN: 0022-2623
DAY: 19
MONTH: Oct
YEAR: 2006
Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 9716531
Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins. Keywords Mesh Terms:
KEYWORDS: Sulfones
MESH TERMS: pharmacology
Chemical & Substance for Abstract: Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins. Information
Substance Name: Gossypol
Registry Number: 303-45-7
Grant and Affiliation Information for Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins.
AFFILIATION: Comprehensive Cancer Center and Department of Internal Medicine, University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, Michigan 48109, USA.
Country: United States
AGENCY: United States NCI
GRANT: U19CA113317
ACRONYM: CA
MEDLINETA: J Med Chem
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins Related Publications